pulmonary review - chest world congress madrid 2014

49
LITERATURE REVIEW

Upload: dr-josep-morera-prat

Post on 26-May-2015

409 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Pulmonary review - Chest World Congress Madrid 2014

LITERATURE REVIEW

Page 2: Pulmonary review - Chest World Congress Madrid 2014

• Advisor to Esteve Teijin in the area of

home respiratory therapy

• I have no other relevant financial

relationships to disclose

Conflict of interest

Page 3: Pulmonary review - Chest World Congress Madrid 2014

• I will not be discussing off-label uses.

Page 4: Pulmonary review - Chest World Congress Madrid 2014

INDEX

• Pneumonia

• Lung Cancer

• Pulmonary Fibrosis

• Pneumonia

Page 5: Pulmonary review - Chest World Congress Madrid 2014

• Lower respiratory tract infection the third most common cause of death in the world (3.5 million deaths/year)

• Streptococcus pneumoniae major cause of morbidity and mortality

worldwide (bacteremia, meningitis, pneumonia and acute otitis media)

• Serious disease mainly in children under two years of age and in elderly

• 1.6 million deaths / year estimated in 2005 (0.7–1 million children)

• PPSV23 less effective than expected

• Pneumococcal strains nonsusceptible to penicillin and erythromycin could have reached 41% by 2004 in the absence of a PCV

PNEUMONIA: INTRODUCTION

WHO, 2013 (http://www.who.int/mediacentre/factsheets/fs310/en/index.html).

Jackson LA. An OficialPublication of the Infectious Diseases Society of America

2008;47:1328–38.

Richard G. et al. N Engl J Med 2014;370:543-51.

McCormick et al. AW Nat Med 2003;9:424-30.

PNEUMONIA

Page 6: Pulmonary review - Chest World Congress Madrid 2014

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

PNEUMONIA

Page 7: Pulmonary review - Chest World Congress Madrid 2014

PNEUMONIA

PUBMED search March 2014. Number of publications related to the topic.

Page 8: Pulmonary review - Chest World Congress Madrid 2014

• PCV7 introduced in USA in 2000

• Major reduction in the incidence of invasive disease in all age groups

• Aim: the early observed reductions in hospitalizations for pneumonia

were sustained throughout the first decade of PCV7 use?

PNEUMONIA

PNEUMONIA: BACKGROUND

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 9: Pulmonary review - Chest World Congress Madrid 2014

• National Inpatient Sample (NIS)

• 1050 hospitals in 44 States

• ICD-9-CM/ pneumonia as 1st diagnosis or meningitis, septicemia or

empyema + pneumonia as 2nd

PNEUMONIA

PNEUMONIA: METHODS/DATA SOURCES

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 10: Pulmonary review - Chest World Congress Madrid 2014

PNEUMONIA

Average Annual Rates of U.S. Hospitalizations for Pneumonia before and after the Introduction of PCV7, According to Age Group.

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 11: Pulmonary review - Chest World Congress Madrid 2014

Hospitalizations for Pneumonia among U.S. Children.

PNEUMONIA

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 12: Pulmonary review - Chest World Congress Madrid 2014

PNEUMONIA

The annual rates of hospitalization for pneumonia from 1997 through 2009.

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 13: Pulmonary review - Chest World Congress Madrid 2014

PNEUMONIA

Hospitalizations for Pneumonia among U.S. Adults.

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 14: Pulmonary review - Chest World Congress Madrid 2014

PNEUMONIA

Differences in Rates of Hospitalization for Pneumonia from Any Cause 3 Years before and 7 to 9 Years after the Introduction of PCV7.

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 15: Pulmonary review - Chest World Congress Madrid 2014

Rates of In-Hospital Death Related to Pneumonia from Any Cause 3 Years before and 7 to 9 Years after the Introduction of PCV7.

PNEUMONIA

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 16: Pulmonary review - Chest World Congress Madrid 2014

PNEUMONIA: CONCLUSIONS

PNEUMONIA

• Declines in hospitalizations for childhood pneumonia were

sustained during the decade after the introduction of PCV7.

• Substantial reductions in hospitalizations for pneumonia among

adults were also observed.

Griffin et al. N Engl J Med Volume 369(2):155-163 July 11, 2013

Page 17: Pulmonary review - Chest World Congress Madrid 2014

PNEUMONIA: MESSAGES

PNEUMONIA

Hammit et al. J Infect Dis. Volume 193(11):1487-94 Apr 27, 2006Weinberger, Lancet 2011; 378: 1962–73Letters to the editor. NEJM 369;17 nejm.org october, 2013Singleton, JAMA. 2007;297:1784-1792

• Probably the “herd” effect protects elderly people– Hammit et al. J Infect Dis. Volume 193(11):1487-94 Apr 27, 2006

• Consequences of Serotype replacement There is not enough datato evaluate the impact

– Weinberger, Lancet 2011; 378: 1962–73

• Species replacement Other pathogens like Staphylococcus aureusis a concern

– Reed A. Siemieniuk M.D. Letters to the editor. NEJM 369;17 nejm.org october, 2013

• Pneumonia complications (Empyema) seems to arise– Alessando Amaddeo. Letters to the editor. NEJM 369;17 nejm.org october, 2013

• We will have to wait to see the effects on mortality

• A decade of PVC13 is open

Page 18: Pulmonary review - Chest World Congress Madrid 2014

INDEX

• Pneumonia

• Lung Cancer

• Pulmonary Fibrosis

• Lung Cancer

Page 19: Pulmonary review - Chest World Congress Madrid 2014

• Lung cancer 1.59 million deaths in 2012

• More individuals die from lung cancer than from colon, breast

and prostate cancer combined

• Rx radiographs and sputum screenings didn’t meet the

expectations, mortality?

• IELCAP results opened the door to RCTs

WHO Fact sheet N°297. Feb 2014. http://www.who.int/mediacentre/factsheets/fs297/en/

Detterbeck, CHEST 2013; 143(5)(Suppl):e78S–e92S

Shlomi, Eur Respir J 2014; in press

LUNG CANCER: INTRODUCTION

LUNG CANCER

Page 20: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

RCT’S:

• DANTE A randomized study of lung cancer screening with spiral

computed tomography: three-year results from the DANTE trial.

• DLCST CT screening for lung cancer brings forward early disease. The

randomised Danish Lung Cancer Screening Trial: status after five

annual screening rounds with low-dose CT.

• NELSON Volumetric computed tomography screening for lung cancer:

three rounds of the NELSON trial.

• ITALUNG Four-year results of low-dose CT screening and nodule

management in the ITALUNG trial.

• NLST NLST Research Team

• >86.000 patients included in total

Am J Respir Crit Care Med. 2009 Sep 1;180(5):445-53.

Thorax. 2012 Apr;67(4):296-301.Singleton, JAMA. 2007;297:1784-1792

Eur Respir J. 2013 Dec;42(6):1659-67.

J Thorac Oncol. 2013 Jul;8(7):866-75.

N Engl J Med. 2011 Aug 4;365(5):395-409.

Page 21: Pulmonary review - Chest World Congress Madrid 2014

Inclusion criteria:

• 55–74 years

• ≥30 pack-years

• Former smokers (within the previous 15 years)

• LDCT vs. chest radiography – 3 annual rounds: T0, T1, T2

• For LDCT, noncalcified nodules of ≥4 mm (maximum diam.) -

positive

NLST Research Team, N Engl J Med 2011;365:395-409.

LUNG CANCER

Page 22: Pulmonary review - Chest World Congress Madrid 2014

NLST Research Team, N Engl J Med 2011;365:395-409.

LUNG CANCER

Page 23: Pulmonary review - Chest World Congress Madrid 2014

Aberle, N Engl J Med 2013;369:920-31.

LUNG CANCER

Page 24: Pulmonary review - Chest World Congress Madrid 2014

PUBMED search March 2014. Number of publications related to the topic.

LUNG CANCER

Page 25: Pulmonary review - Chest World Congress Madrid 2014

• LDCT diagnosed more cancer (1,1% vs 0,7%)

• More stage I Ca in LDCT group

• Tendency of stage-shift

• Sensibility of LDCT 93,8% and Specificity 73,4%

• In LDCT group more positive screenings and more Dg procedures

NLST Research Team, N Engl J Med 2013;368:1980-91.

LUNG CANCER

Page 26: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

Aberle, N Engl J Med 2013;369:920-31.

Data extracted from original

Page 27: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

Aberle, N Engl J Med 2013;369:920-31.

Data extracted from original

Page 28: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

NLST Research Team, N Engl J Med 2013;368:1980-91.

Sensitivity, specificity and positive predictive value for LDCT in T1 and T2.Data extracted from original

Page 29: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

NLST Research Team, N Engl J Med 2013;368:1980-91.

T0; Number of patients diagnosed of lung cancer according to Stage.Data extracted from original

Page 30: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

Aberle, N Engl J Med 2013;369:920-31.

T1; Number of patients diagnosed of lung cancer acording to Stage.Data extracted from original

Page 31: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

Aberle, N Engl J Med 2013;369:920-31.

T2; Number of patients diagnosed of lung cancer acording to Stage.Data extracted from original

Page 32: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

NLST Research Team, N Engl J Med 2013;368:1980-91.

T1; PPV according to lung nodule size.Data extracted from original

Page 33: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

Aberle, N Engl J Med 2013;369:920-31.

T2; PPV according to lung nodule size.Data extracted from original

Page 34: Pulmonary review - Chest World Congress Madrid 2014

LUNG CANCER

Aberle, N Engl J Med 2013;369:920-31.

T0; PPV according to lung nodule size.Data extracted from original

Page 35: Pulmonary review - Chest World Congress Madrid 2014

• Low-dose CT detects more lung cancers than radiography

• Stage shift toward early-stage in non–small-cell lung cancers

• Performance characteristics of low-dose CT may be

enhanced

LUNG CANCER

LUNG CANCER: CONCLUSIONS

Aberle, N Engl J Med 2013;369:920-31.

Page 36: Pulmonary review - Chest World Congress Madrid 2014

• Selection criteria–Detterbeck, CHEST 2013; 143(5)(Suppl):e78S–e92S

–Kovalchik, N Engl J Med 2013;369:245-54

• Results may improve with the volumetric study –Horeweg, Eur Respir J 2013; 42: 1659–1667

• Results may also improve with pet-ct (>8mm) –Shlomi, Eur Respir J. 2014 Feb 13.

• Awareness of concept of slow-growing lung cancer!–Infante, Eur Respir J 2013; 42: 1706–1722

• Biomarkers as additional screening tool–Sozzi, J Clin Oncol 2014 32:768-773.

LUNG CANCER: MESSAGES 1

LUNG CANCER

Detterbeck, CHEST 2013; 143(5)(Suppl):e78S–e92SHoreweg, Eur Respir J 2013; 42: 1659–1667Shlomi, Eur Respir J. 2014 Feb 13.Infante, Eur Respir J 2013; 42: 1706–1722Kovalchik, N Engl J Med 2013;369:245-54

Page 37: Pulmonary review - Chest World Congress Madrid 2014

Benefits

• Effect on mortality

• Effect on smoking

behavior

Harms

• False positives

• Diagnostic procedure

complications

• Overdiagnosis

• Radiation exposure

• Quality of life

Screening could be performed such

that benefits outweigh the harms.

LUNG CANCER

Bach, JAMA. 2012;307(22):2418-2429

LUNG CANCER: MESSAGES 2

Page 38: Pulmonary review - Chest World Congress Madrid 2014

INDEX

• Pneumonia

• Lung Cancer

• Pulmonary Fibrosis• Pulmonary Fibrosis

Page 39: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS: INTRODUCTION

PULMONARY FIBROSIS

Navaratnam et al., Thorax 2011;66(6):462-7

Page 40: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

Kern et al., Ann Intern Med 1998;129(4):261-72

Page 41: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

Taken from: http://cxjinxing.en.alibaba.com/product/514495564-213102141/Nylon_flock_powder.html

Page 42: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

Turcotte, CHEST 2013; 143(6):1642–1648

Page 43: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

Navaratnam et al., Thorax 2011;66(6):462-7

PUBMED search March 2014. Number of publications related to the topic.

Page 44: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

Turcotte, CHEST 2013; 143(6):1642–1648

Page 45: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

Turcotte, CHEST 2013; 143(6):1642–1648

Page 46: Pulmonary review - Chest World Congress Madrid 2014

Natural history of FWL disease. Adapted from original

PULMONARY FIBROSIS

Turcotte, CHEST 2013; 143(6):1642–1648

Page 47: Pulmonary review - Chest World Congress Madrid 2014

• In summary, the natural history of FWL includes complete resolution;

persistent, but stable ILD with a restrictive pulmonary function deficit;

mixed obstructive/restrictive pulmonary function deficits; and

progressive fibrosis leading to respiratory failure, pulmonary

hypertension, and death.

PULMONARY FIBROSIS

PULMONARY FIBROSIS: CONCLUSIONS

Turcotte, CHEST 2013; 143(6):1642–1648

Page 48: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

• Natural history of the interstitial lung diseases is not uniform and even

can be reversed

• It is important, when possible, to determine the cause of the disease–Am J Respir Crit Care Med. 2014 Jan 1;189(1):48-56.

PULMONARY FIBROSIS: MESSAGES

Page 49: Pulmonary review - Chest World Congress Madrid 2014

PULMONARY FIBROSIS

Thanks a lot!